Morvel Laboratories Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
as on 30-06-2024
- Paid Up Capital ₹ 1.30 M
as on 30-06-2024
- Company Age 41 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 12.86 Cr
as on 30-06-2024
- Satisfied Charges ₹ 3.55 M
as on 30-06-2024
- Revenue 32.95%
(FY 2023)
- Profit 5.93%
(FY 2023)
- Ebitda 28.48%
(FY 2023)
- Net Worth -155.71%
(FY 2023)
- Total Assets -12.96%
(FY 2023)
About Morvel Laboratories
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 1.30 M.
The company currently has active open charges totaling ₹12.86 Cr. The company has closed loans amounting to ₹3.55 M, as per Ministry of Corporate Affairs (MCA) records.
Rikin Patel, Rinku Patel, and Shardaben Patel serve as directors at the Company.
- CIN/LLPIN
U24231GJ1983PTC006187
- Company No.
006187
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
16 May 1983
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Mahesana, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Morvel Laboratories Private Limited offer?
Morvel Laboratories Private Limited offers a wide range of products and services, including TB, Tumor & Cancer Drugs, Anti Cancer Injection, Anti Infective Drugs & Medicines, Anti Allergic Drug, Animal Medicines & Health Care, Veterinary Medicines, Sexual Wellness Products, Fertility Enhancer, Antibiotic Tablets, Capsule & Syrup, Cardiovascular Drugs & Medication.
Who are the key members and board of directors at Morvel Laboratories?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rikin Patel  | Director | 08-Sep-2004 | Current |
| Rinku Patel | Director | 09-Nov-2013 | Current |
| Shardaben Patel | Director | 09-Nov-2013 | Current |
Financial Performance of Morvel Laboratories.
Morvel Laboratories Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 32.95% increase. The company also saw a slight improvement in profitability, with a 5.93% increase in profit. The company's net worth observed a substantial decline by a decrease of 155.71%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Morvel Laboratories?
In 2023, Morvel Laboratories had a public holding of 32.31%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 07 Nov 2022 | ₹6.00 M | Open |
Axis Bank Limited Creation Date: 10 Feb 2022 | ₹1.67 Cr | Open |
Axis Bank Limited Creation Date: 17 Aug 2021 | ₹2.00 Cr | Open |
How Many Employees Work at Morvel Laboratories?
Morvel Laboratories has a workforce of 41 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Morvel Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Morvel Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
